{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:13:00Z","timestamp":1777093980829,"version":"3.51.4"},"reference-count":25,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Autoimmune hypocalciuric hypercalcemia (AHH) is an acquired disorder caused by the presence of blocking autoantibodies against the calcium-sensing receptor (CaSR). Few cases of this condition have been described to date in the literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objectives of this study were to describe 2 patients in whom the presence of AHH was suspected and to assess the patients for the presence of CaSR antibodies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CaSR antibodies were detected and characterised by immunoprecipitation assays, CaSR peptide ELISAs, and functional assays based on the calcium-stimulated accumulation of inositol-1-phosphate in a mammalian cell line expressing the CaSR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Both patients presented with an acquired form of hypocalciuric hypercalcemia. Mutational analyses of CASR, GNA11, and AP2S1 for familial hypocalciuric hypercalcemia were negative. According to the presence of Hashimoto\u2019s disease in 1 patient and latent autoimmune diabetes of adulthood and thyroid autoimmunity in the other, AHH was suspected. Immunoprecipitation assays detected CaSR antibodies in both patients. Analysis of the antibody binding sites revealed 2 main epitopes at amino acids 41\u201369 and 114\u2013126. Preincubation with purified CaSR antibodies against epitope 114\u2013126 resulted in a significant decrease in inositol-1-phophate accumulation upon calcium-stimulation of mammalian cells expressing the CaSR, suggesting that the antibodies had receptor-blocking activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>AHH is to be suspected in patients with an acquired biochemical pattern of PTH-dependant hypocalciuric hypercalcemia, especially in those with other concomitant autoimmune diseases. Diagnosis by means of detecting CaSR antibodies may help to better characterise this probably under-reported condition.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa219","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T15:45:54Z","timestamp":1587397554000},"page":"2229-2236","source":"Crossref","is-referenced-by-count":7,"title":["Autoimmune Hypercalcemia Due to Autoantibodies Against the Calcium-sensing Receptor"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-3938","authenticated-orcid":false,"given":"Inka","family":"Mi\u00f1ambres","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"},{"name":"Departament of Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas (CIBER-DEM), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Corcoy","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"},{"name":"Departament of Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"CIBER de Bioingenier\u00eda, Biomateriales y Nanotecnolog\u00eda (CIBER-BBN), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P","family":"Weetman","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Helen","family":"Kemp","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"3","key":"2021122116310959100_CIT0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.beem.2013.02.006","article-title":"Role of the calcium-sensing receptor in extracellular calcium homeostasis","volume":"27","author":"Brown","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"1","key":"2021122116310959100_CIT0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"2021122116310959100_CIT0003","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"issue":"7","key":"2021122116310959100_CIT0004","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell."},{"issue":"5","key":"2021122116310959100_CIT0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"10","key":"2021122116310959100_CIT0006","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122116310959100_CIT0007","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4158\/EP11272.RA","article-title":"Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications","volume":"18","author":"Eldeiry","year":"2012","journal-title":"Endocr Pract."},{"issue":"5","key":"2021122116310959100_CIT0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122116310959100_CIT0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/EJE-16-0842","article-title":"AP2S1 and GNA11 mutations \u2013 not a common cause of familial hypocalciuric hypercalcemia","volume":"176","author":"Hovden","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"26","key":"2021122116310959100_CIT0010","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med."},{"issue":"1","key":"2021122116310959100_CIT0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet."},{"issue":"1","key":"2021122116310959100_CIT0012","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2002-020249","article-title":"A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor","volume":"88","author":"Kifor","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122116310959100_CIT0013","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"N Engl J Med."},{"issue":"13","key":"2021122116310959100_CIT0014","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1073\/pnas.0701290104","article-title":"An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations","volume":"104","author":"Makita","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2021122116310959100_CIT0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.ajkd.2013.04.023","article-title":"Acquired hypocalciuric hypercalcemia in a patient with CKD","volume":"62","author":"Kuo","year":"2013","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"2021122116310959100_CIT0016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1210\/jc.2010-1739","article-title":"Autoimmune hypocalciuric hypercalcemia unresponsive to glucocorticoid therapy in a patient with blocking autoantibodies against the calcium-sensing receptor","volume":"96","author":"Pallais","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122116310959100_CIT0017","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2169\/naika.103.1180","article-title":"Case report; a case of acquired hypocalciuric hypercalcemia due to autoantibody against the calcium-sensing receptor","volume":"103","author":"Seino","year":"2014","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"1","key":"2021122116310959100_CIT0018","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-17-0172","article-title":"Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review","volume":"177","author":"Song","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122116310959100_CIT0019","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jc.2006-2466","article-title":"The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1","volume":"92","author":"Gavalas","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122116310959100_CIT0020","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4049\/jimmunol.1701527","article-title":"Calcium-Sensing receptor autoantibodies in patients with autoimmune polyendocrine syndrome type 1: epitopes, specificity, functional affinity, igg subclass, and effects on receptor activity","volume":"201","author":"Habibullah","year":"2018","journal-title":"J Immunol."},{"issue":"1","key":"2021122116310959100_CIT0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/jbmr.090703","article-title":"Mapping of human autoantibody binding sites on the calcium-sensing receptor","volume":"25","author":"Kemp","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2021122116310959100_CIT0022","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1582-4934.2007.00096.x","article-title":"Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators","volume":"11","author":"Hu","year":"2007","journal-title":"J Cell Mol Med."},{"issue":"34","key":"2021122116310959100_CIT0023","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1074\/jbc.M102977200","article-title":"Human Ca(2+) receptor extracellular domain. Analysis of function of lobe I loop deletion mutants","volume":"276","author":"Reyes-Cruz","year":"2001","journal-title":"J Biol Chem."},{"issue":"7","key":"2021122116310959100_CIT0024","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122116310959100_CIT0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2169\/internalmedicine.44.60","article-title":"Primary hyperparathyroidism presumably caused by chronic parathyroiditis manifesting from hypocalcemia to severe hypercalcemia","volume":"44","author":"Furuto-Kato","year":"2005","journal-title":"Intern Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa219\/33105559\/dgaa219.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/2229\/41840730\/jcem_105_7_2229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/2229\/41840730\/jcem_105_7_2229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:49:32Z","timestamp":1640105372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/7\/2229\/5822860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,4,20]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa219","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,4,20]]}}}